fashion -WSS

fashion

author：comprehensive 2025-09-27 12:48:14 - browse：2

To scientists' surprise in a new study, a common genetic deletion in schizophrenia cases was linked to problems in mitochondria. Adobe

The heritable nature of schizophrenia has been known for about a century. But researchers are still trying to learn how genes that have been linked to an increased risk of the disease actually lead to schizophrenia.

For decades, those genetic underpinnings of schizophrenia have fascinated Jennifer Mulle, an associate professor at the Rutgers Center for Advanced Biotechnology and Medicine. When she was a master’s student in public health, she set out to locate a place in the DNA that held the secrets of the condition. “We did really beautifully, carefully designed studies,” she said. “And there was nothing.”

In the early 2000s, before they knew many genes factor into schizophrenia, researchers were looking for a single gene that would be culpable for the devastating illness. Mulle spent nearly a decade on the hunt, through her Ph.D. program and into her postdoctoral fellowship at Emory University. Under the mentorship of Stephen Warren, who founded the medical school’s department of human genetics and unearthed the genetics of fragile X syndrome, she finally found something.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Stigma and the return of syphilis

WSS

Focused ultrasound for uterine fibroids: an uphill battle

Lab trade group sues FDA to halt regulation of lab

Lab trade group sues FDA to halt regulation of lab

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Insmed lung disease drug hits target in key Phase 3 trial

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

explore

fashion

knowledge

Continuity nursing helped my family in our darkest PICU moments

Lab trade group sues FDA to halt regulation of lab

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Health insurers say they are turning to AI to cut costs, improve care

Trump demands the U.S. pay no more for drugs than other countries … again

iTeos Therapeutics debuts first data on TIGIT

Medicare details structure of new drug price negotiation program

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

knowledge

Do more moles mean more problems? Not so, says new study

Stigma and the return of syphilis

Insmed lung disease drug hits target in key Phase 3 trial

Focused ultrasound for uterine fibroids: an uphill battle

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

explore

entertainment

hotspot

leisure time